

[ Fri, Nov 10th 2017
] - WOPRAI
[ Fri, Nov 10th 2017
] - WOPRAI
[ Fri, Nov 10th 2017
] - WOPRAI
[ Fri, Nov 10th 2017
] - WOPRAI
[ Fri, Nov 10th 2017
] - WOPRAI
[ Fri, Nov 10th 2017
] - WOPRAI
[ Fri, Nov 10th 2017
] - WOPRAI
[ Fri, Nov 10th 2017
] - WOPRAI
[ Fri, Nov 10th 2017
] - WOPRAI
[ Fri, Nov 10th 2017
] - WOPRAI
[ Fri, Nov 10th 2017
] - WOPRAI
[ Fri, Nov 10th 2017
] - WOPRAI
[ Fri, Nov 10th 2017
] - WOPRAI
[ Fri, Nov 10th 2017
] - WOPRAI
[ Fri, Nov 10th 2017
] - WOPRAI
[ Fri, Nov 10th 2017
] - WOPRAI
[ Fri, Nov 10th 2017
] - WOPRAI
[ Fri, Nov 10th 2017
] - WOPRAI

[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
Jay Olson Initiated (BIIB) at Buy and Held Target at $350 on, Nov 9th, 2017
Jay Olson of Oppenheimer, Initiated "Biogen Inc." (BIIB) at Buy and Held Target at $350 on, Nov 9th, 2017.
Jay has made no other calls on BIIB in the last 4 months.
There are 14 other peers that have a rating on BIIB. Out of the 14 peers that are also analyzing BIIB, 5 agree with Jay's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Sumant Kulkarni of "Canaccord Genuity" Initiated at Hold and Held Target at $340 on, Friday, October 27th, 2017
- Carter Gould of "UBS" Maintained at Hold with Increased Target to $318 on, Wednesday, October 25th, 2017
- Robyn Karnauskas of "Citigroup" Downgraded from Strong Buy to Hold on, Monday, October 23rd, 2017
- Brian Abrahams of "RBC Capital" Initiated at Hold and Held Target at $319 on, Friday, September 15th, 2017
- Eun Yang of "Jefferies" Initiated at Hold and Held Target at $310 on, Tuesday, July 11th, 2017
These are the ratings of the 9 analyists that currently disagree with Jay
- Ian Somaiya of "BMO Capital" Maintained at Buy with Increased Target to $386 on, Monday, November 6th, 2017
- Jeffrey Silber of "BMO Capital" Upgraded from Hold to Buy on, Wednesday, October 25th, 2017
- Adnan Butt of "Guggenheim" Initiated at Strong Buy and Held Target at $402 on, Tuesday, October 24th, 2017
- Christopher Raymond of "Piper Sandler" Initiated at Buy and Held Target at $390 on, Monday, October 23rd, 2017
- Ying Huang of "B of A Securities" Maintained at Strong Buy with Increased Target to $365 on, Wednesday, October 18th, 2017
- Thomas Shrader of "Stifel" Upgraded from Hold to Strong Buy on, Tuesday, October 17th, 2017
- Salim Syed of "Mizuho" Upgraded from Hold to Strong Buy on, Tuesday, October 17th, 2017
- Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy on, Thursday, October 5th, 2017
- Terence Flynn of "Goldman Sachs" Upgraded at Strong Buy on, Wednesday, August 16th, 2017